Biomarkers in pulmonary hypertension: what do we know?

V Foris, G Kovacs, M Tscherner, A Olschewski… - Chest, 2013 - Elsevier
Pulmonary hypertension (PH) is a hemodynamic condition that has a poor prognosis and
can lead to right-sided heart failure. It may result from common diseases such as left-sided …

Circulating blood-based biomarkers in pulmonary hypertension

M Banaszkiewicz, A Gąsecka, S Darocha… - Journal of Clinical …, 2022 - mdpi.com
Pulmonary hypertension (PH) is a serious hemodynamic condition, characterized by
increased pulmonary vascular resistance (PVR), leading to right heart failure (HF) and death …

The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approach

LW Geenen, VJM Baggen, T Koudstaal… - American Heart …, 2019 - Elsevier
Background This study aimed to investigate the prognostic value of six different biomarkers
in patients with pulmonary hypertension (PH) and to explore whether a multi-biomarker …

The potential of biomarkers in pulmonary arterial hypertension

JL Cracowski, HH Leuchte - The American journal of cardiology, 2012 - Elsevier
Effective management of patients with pulmonary arterial hypertension (PAH) requires
comprehensive prognostic evaluation in order to determine optimal management strategies …

[HTML][HTML] Prognostic stratification in pulmonary hypertension: a multi-biomarker approach

R Plácido, N Cortez-Dias, SR Martins… - Revista Portuguesa de …, 2017 - Elsevier
Introduction Pulmonary hypertension (PH) covers a group of conditions characterized by an
increase in pulmonary vascular resistance leading to right ventricular failure. Risk …

The changing face of pulmonary hypertension diagnosis: a historical perspective on the influence of diagnostics and biomarkers

JL Hewes, JY Lee, KA Fagan… - Pulmonary …, 2020 - journals.sagepub.com
Pulmonary hypertension is a complex, multifactorial disease that results in right heart failure
and premature death. Since the initial reports of pulmonary hypertension in the late 1800s …

Circulating biomarkers in pulmonary arterial hypertension: update and future direction

B Pezzuto, R Badagliacca, R Poscia, S Ghio… - The Journal of Heart and …, 2015 - Elsevier
Pulmonary arterial hypertension (PAH) is a complex disease with a poor prognosis. In recent
years, great advances have occurred in our understanding of the pathophysiologic …

Identification of new prognostic factors of pulmonary hypertension

Y Miura, Y Fukumoto, K Sugimura, M Oikawa… - Circulation …, 2010 - jstage.jst.go.jp
Background: Pulmonary hypertension (PH) still remains a serious disease, for which the
plasma level of brain natriuretic peptide (BNP) and hemodynamic variables (eg, cardiac …

[HTML][HTML] Pulmonary hypertension–new trends of diagnostic and therapy

S Pesto, Z Begic, S Prevljak, E Pecar, N Kukavica… - Medical …, 2016 - ncbi.nlm.nih.gov
Pulmonary hypertension is a pathophysiological state hemodynamically defined as the
increase of the mean pulmonary arterial pressure above 25, or 30 mmHg at rest, measured …

[HTML][HTML] Pulmonary hypertension and indicators of right ventricular function

CL Von Siebenthal, JD Aubert, P Mitsakis… - Frontiers in …, 2016 - frontiersin.org
Pulmonary hypertension (PH) is a rare disease, whose underlying mechanisms are not fully
understood. It is characterized by pulmonary arterial vasoconstriction and vessels wall …